SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

81,106.65 107.25
( 0.13%)

Global Indices

Nasdaq

52,540.96 1,234.23
(2.41%)

Dow Jones

7,582.98 185.12
(2.50%)

Hang Seng

60,560.79 1,785.29
(3.04%)

Nikkei 225

10,782.38 -0.49
(0.00%)

Forex

USD-INR

94.03 -0.38
(-0.40%)

EUR-INR

104.75 -1.32
(-1.24%)

GBP-INR

125.52 -1.66
(-1.31%)

JPY-INR

0.59 0.00
(-0.72%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Dr Reddys Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500124

INE089A01031

382.3238894

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

DRREDDY

119.09

115685.11

EPS(TTM)

Face Value()

Div & Yield %

11.63

0.58

Back

Radico Khaitan consolidated net profit rises 66.49% in the September 2026 quarter

Oct 27,2026

Net profit of Radico Khaitan rose 66.49% to Rs 232.35 crore in the quarter ended September 2026 as against Rs 139.56 crore during the previous quarter ended September 2025. Sales rose 16.81% to Rs 1745.10 crore in the quarter ended September 2026 as against Rs 1493.93 crore during the previous quarter ended September 2025.

Particulars	Quarter Ended
	Sep. 2026	Sep. 2025	% Var.
Sales	1745.10	1493.93	17
OPM %	20.47	15.91	-
PBDT	352.36	224.32	57
PBT	309.19	186.94	65
NP	232.35	139.56	66

81,106.65 107.25 ( 0.13%)

52,540.96 1,234.23 (2.41%)

7,582.98 185.12 (2.50%)

60,560.79 1,785.29 (3.04%)

10,782.38 -0.49 (0.00%)

94.03 -0.38 (-0.40%)

104.75 -1.32 (-1.24%)

125.52 -1.66 (-1.31%)

0.59 0.00 (-0.72%)